Inhibiting Invariant Natural Killer T-Cell Activation: A Promising Strategy against Pulmonary Fibrosis
Am J Respir Crit Care Med
.
2024 Nov 15;210(10):1278.
doi: 10.1164/rccm.202408-1513LE.
Authors
Taro Yasuma
1
,
Hajime Fujimoto
2
,
Corina N D'Alessandro-Gabazza
1
,
Esteban C Gabazza
1
2
3
,
Osamu Hataji
3
,
Tetsu Kobayashi
2
Affiliations
1
Department of Immunology and.
2
Department of Pulmonary and Critical Care Medicine, Faculty of Medicine, Graduate School of Medicine, Mie University, Tsu, Japan; and.
3
Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan.
PMID:
39270214
PMCID:
PMC11568448
DOI:
10.1164/rccm.202408-1513LE
No abstract available
Publication types
Letter